SMTL ID : 6hd6.2 (1 other biounit)

ABL1 IN COMPLEX WITH COMPOUND6 AND IMATINIB (STI-571)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x STI: 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE(Non-covalent)

STI.1: 24 residues within 4Å: Chain A: L.26, Y.31, V.34, A.47, V.48, K.49, E.64, V.67, M.68, I.71, V.77, I.91, T.93, F.95, M.96, G.99, F.137, I.138, H.139, R.140, L.148, A.158, D.159, F.160 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:L.26, A:Y.31, A:V.34, A:A.47, A:E.64, A:I.71, A:I.91, A:T.93, A:L.148, A:D.159, A:F.160 Hydrogen bonds: A:E.64, A:E.64, A:T.93, A:T.93, A:M.96, A:D.159 pi-Stacking: A:Y.31, A:F.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schoepfer, J. et al., Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1. J. Med. Chem. (2018)

Release Date

2018-09-12

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence